High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients
2012 · Japanese Journal of Clinical Oncology · 95 citations
https://doi.org/10.1093/jjco/hys001
N
Nobuyasu Yoshimoto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
954
Citations
17
h-index
21
i10-index
Nobuyasu Yoshimoto is an academic researcher from Sapporo Higashi Tokushukai Hospital. The author has contributed to research in topics: Estrogen and related hormone effects & Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research. The author has an h-index of 17, co-authored 46 publications.
ORCID: 0000-0002-4935-0234Papers by this author
worksA case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment
2008 · Breast Cancer · 33 citations
https://doi.org/10.1007/s12282-008-0060-1
High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancer
2011 · International Journal of Clinical Oncology · 24 citations
https://doi.org/10.1007/s10147-011-0215-5
FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer
2013 · Breast Cancer · 21 citations
https://doi.org/10.1007/s12282-013-0482-2
HER2 Mutation Status in Japanese HER2-negative Breast Cancer Patients
2014 · Japanese Journal of Clinical Oncology · 12 citations
https://doi.org/10.1093/jjco/hyu053
HER2 mutation status in Japanese HER2-positive breast cancer patients
2015 · Breast Cancer · 10 citations
https://doi.org/10.1007/s12282-015-0659-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat